These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8308769)

  • 1. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.
    McKendry RJ; Dale P
    J Rheumatol; 1993 Nov; 20(11):1850-6. PubMed ID: 8308769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
    Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
    J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate.
    Carroll GJ; Thomas R; Phatouros CC; Atchison MH; Leslie AL; Cook NJ; D'Souza I
    J Rheumatol; 1994 Jan; 21(1):51-4. PubMed ID: 8151587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
    Nakazaki S; Murayama T; Katoh S
    Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis].
    Tahiri L; Allali F; Jroundi I; Abouqal R; Hajjaj-Hassouni N
    Sante; 2006; 16(3):167-72. PubMed ID: 17284392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose methotrexate in rheumatoid arthritis.
    Steinsson K; Weinstein A; Korn J; Abeles M
    J Rheumatol; 1982; 9(6):860-6. PubMed ID: 7161777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.
    Sany J; Anaya JM; Lussiez V; Couret M; Combe B; Daures JP
    J Rheumatol; 1991 Sep; 18(9):1323-7. PubMed ID: 1757932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
    Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D
    Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancytopenia associated with low dose methotrexate therapy. A regional survey.
    al-Awadhi A; Dale P; McKendry RJ
    J Rheumatol; 1993 Jul; 20(7):1121-5. PubMed ID: 8371202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients.
    McKendry RJ; Cyr M
    Arch Intern Med; 1989 Mar; 149(3):685-9. PubMed ID: 2919941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.